logo

For the Inventor, By the Inventor

Sayama, Japan

Konstanty Wierzba

This inventor holds 8 USPTO granted patents. Top assignees: Taiho Pharmaceutical Company Limited, Sosei Co., Ltd., Other. Active years: 1995-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konstanty Wierzba. Retrieved from https://idiyas.com/inventor/konstanty-wierzba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Itano, JP (1995)
  • Saitama, JP (1996)
  • Iruma-gun, JP (1996)
  • Iruma, JP (1996)
  • Sayama, JP (1998 - 2007)

Company Filing History:

goldMedal6 out of 320 
 
Taiho Pharmaceutical Company Limited
 patents
silverMedal1 out of 2 
 
Sosei Co., Ltd.
 patents
bronzeMedal1 out of 834,453 
Other
 patents

Years Active: 1995-2007

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7192763 - [object Object] (2007-03-20),
2. 6613759 - Substance GM-95, process for producing the same and utilization thereof (2003-09-02),
3. 6255314 - Cancerous metastasis inhibitors containing uracil derivatives (2001-07-03),
4. 5750515 - Cancer metastasis inhibitor (1998-05-12),
5. 5571914 - 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable (1996-11-05),
6. 5536847 - 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable (1996-07-16),
7. 5489698 - 4-Desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable (1996-02-06),
8. 5420117 - 5-substituted uridine derivatives (1995-05-30),

Title: The Innovative Contributions of Konstanty Wierzba

Introduction

Konstanty Wierzba is a prominent inventor based in Sayama, Japan, recognized for his significant contributions to pharmaceutical innovations. With 8 patents to his name, he has made considerable strides in the field of medicine, particularly in the development of compounds with potential antitumor properties.

Latest Patents

Among Konstanty Wierzba's latest patents is a novel compound characterized by a specific formula, which includes processes for its production, pharmaceutical compositions, and methods for treating tumors through administration of the compound. The compound demonstrates remarkable antitumor action and holds promise as a medicinal substance. Additionally, he has patented Substance GM-95, detailing its production process and utilization, showcasing his commitment to advancing medical science.

Career Highlights

Wierzba has a notable background in the pharmaceutical industry, having worked with Taiho Pharmaceutical Company Limited. His tenure at such a reputable organization has facilitated his research and development efforts, allowing him to create impactful medicinal compounds.

Collaborations

Throughout his career, Konstanty Wierzba has collaborated with esteemed colleagues, including Tadafumi Terada and Katsuhiko Fujimoto. Their collective expertise highlights the importance of teamwork in driving innovation within the pharmaceutical sector.

Conclusion

Konstanty Wierzba exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to developing new compounds and methods for treating tumors underlines his significant role as an inventor. As he continues to contribute to the field, his work is expected to inspire future advancements in medicine and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…